271 related articles for article (PubMed ID: 15518023)
1. Endemic multidrug-resistant Pseudomonas aeruginosa in critically ill patients.
Ortega B; Groeneveld AB; Schultsz C
Infect Control Hosp Epidemiol; 2004 Oct; 25(10):825-31. PubMed ID: 15518023
[TBL] [Abstract][Full Text] [Related]
2. Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment.
Philippe E; Weiss M; Shultz JM; Yeomans F; Ehrenkranz NJ
Clin Perform Qual Health Care; 1999; 7(2):83-7. PubMed ID: 10747571
[TBL] [Abstract][Full Text] [Related]
3. An integrated approach to control a prolonged outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit.
Knoester M; de Boer MG; Maarleveld JJ; Claas EC; Bernards AT; de Jonge E; van Dissel JT; Veldkamp KE
Clin Microbiol Infect; 2014 Apr; 20(4):O207-15. PubMed ID: 24707852
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of nosocomial colonization and infection due to Pseudomonas aeruginosa in mechanically ventilated patients.
Berthelot P; Grattard F; Mahul P; Pain P; Jospé R; Venet C; Carricajo A; Aubert G; Ros A; Dumont A; Lucht F; Zéni F; Auboyer C; Bertrand JC; Pozzetto B
Intensive Care Med; 2001 Mar; 27(3):503-12. PubMed ID: 11355118
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients.
Agodi A; Barchitta M; Cipresso R; Giaquinta L; Romeo MA; Denaro C
Intensive Care Med; 2007 Jul; 33(7):1155-1161. PubMed ID: 17503016
[TBL] [Abstract][Full Text] [Related]
6. Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors.
Trinh TD; Zasowski EJ; Claeys KC; Lagnf AM; Kidambi S; Davis SL; Rybak MJ
Diagn Microbiol Infect Dis; 2017 Sep; 89(1):61-66. PubMed ID: 28716451
[TBL] [Abstract][Full Text] [Related]
7. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients.
Adachi JA; Perego C; Graviss L; Dvorak T; Hachem R; Chemaly RF; Raad II
Am J Infect Control; 2009 Aug; 37(6):442-6. PubMed ID: 19118923
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for Pseudomonas aeruginosa acquisition in intensive care units: a prospective multicentre study.
Venier AG; Leroyer C; Slekovec C; Talon D; Bertrand X; Parer S; Alfandari S; Guerin JM; Megarbane B; Lawrence C; Clair B; Lepape A; Perraud M; Cassier P; Trivier D; Boyer A; Dubois V; Asselineau J; Rogues AM; Thiébaut R;
J Hosp Infect; 2014 Oct; 88(2):103-8. PubMed ID: 25155240
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa susceptible only to colistin in intensive care unit patients.
Mastoraki A; Douka E; Kriaras I; Stravopodis G; Manoli H; Geroulanos S
Surg Infect (Larchmt); 2008 Apr; 9(2):153-60. PubMed ID: 18426347
[TBL] [Abstract][Full Text] [Related]
10. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes.
Parker CM; Kutsogiannis J; Muscedere J; Cook D; Dodek P; Day AG; Heyland DK;
J Crit Care; 2008 Mar; 23(1):18-26. PubMed ID: 18359417
[TBL] [Abstract][Full Text] [Related]
11. Acquisition of Pseudomonas aeruginosa and its resistance phenotypes in critically ill medical patients: role of colonization pressure and antibiotic exposure.
Cobos-Trigueros N; Solé M; Castro P; Torres JL; Hernández C; Rinaudo M; Fernández S; Soriano Á; Nicolás JM; Mensa J; Vila J; Martínez JA
Crit Care; 2015 May; 19(1):218. PubMed ID: 25936721
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria.
Pontikis K; Karaiskos I; Bastani S; Dimopoulos G; Kalogirou M; Katsiari M; Oikonomou A; Poulakou G; Roilides E; Giamarellou H
Int J Antimicrob Agents; 2014 Jan; 43(1):52-9. PubMed ID: 24183799
[TBL] [Abstract][Full Text] [Related]
13. Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.
Fernández-Barat L; Ferrer M; De Rosa F; Gabarrús A; Esperatti M; Terraneo S; Rinaudo M; Li Bassi G; Torres A
J Infect; 2017 Feb; 74(2):142-152. PubMed ID: 27865895
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa.
Eagye KJ; Kuti JL; Nicolau DP
Infect Control Hosp Epidemiol; 2009 Aug; 30(8):746-52. PubMed ID: 19583513
[TBL] [Abstract][Full Text] [Related]
15. Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.
Peña C; Guzmán A; Suarez C; Dominguez MA; Tubau F; Pujol M; Gudiol F; Ariza J
Antimicrob Agents Chemother; 2007 Jun; 51(6):1967-71. PubMed ID: 17420207
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
[TBL] [Abstract][Full Text] [Related]
17. [The vicissitude of pathogenic bacteria isolated from critically ill patients in an intensive care unit during a period of using antibiotics].
Wei HJ; Liu LL; Xiaoli LY; Wang YP; Huang D; Pian HY; Zhu YC
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):36-9. PubMed ID: 19141190
[TBL] [Abstract][Full Text] [Related]
18. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit.
Nseir S; Blazejewski C; Lubret R; Wallet F; Courcol R; Durocher A
Clin Microbiol Infect; 2011 Aug; 17(8):1201-8. PubMed ID: 21054665
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
Aloush V; Navon-Venezia S; Seigman-Igra Y; Cabili S; Carmeli Y
Antimicrob Agents Chemother; 2006 Jan; 50(1):43-8. PubMed ID: 16377665
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for hospitalized patients with resistant or multidrug-resistant
Raman G; Avendano EE; Chan J; Merchant S; Puzniak L
Antimicrob Resist Infect Control; 2018; 7():79. PubMed ID: 29997889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
